Veronique Lecault - 31 Dec 2021 Form 5 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Operating Officer, Director
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
31 Dec 2021
Transactions value $
$0
Form type
5
Filing time
03 Feb 2022, 18:00:41 UTC
Previous filing
09 Dec 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Gift $0 -83,333 -5.86% $0.000000 1,339,333 30 Nov 2021 Direct F1
transaction ABCL Common Shares Gift $0 -250,000 -15.7% $0.000000 1,339,333 08 Dec 2021 Direct F2
holding ABCL Common Shares 7,155,008 31 Dec 2021 See Footnote F3
holding ABCL Common Shares 273,630 31 Dec 2021 See Footnote F4
holding ABCL Common Shares 61,580 31 Dec 2021 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents a charitable donation of 83,333 common shares the reporting person donated on November 30, 2021.
F2 This transaction represents a charitable donation of 250,000 common shares the reporting person donated on December 8, 2021.
F3 These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The reporting person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The reporting person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
F4 These shares are held by Slomo Family Trust. The reporting person is a co-trustee of the Slomo Family Trust. The reporting person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.